CFO Research Results 2021


This Research, conducted at our CFO Retreat, provides a fascinating insight into the challenges leaders continue to face as a result of the pandemic and the opportunities that may lie ahead over the next 12 months.

Key findings from Criticaleye's CFO Research:

  • Cost reduction and organisational design have moved up the priority list 
  • 67% of finance leaders feel isolated in their role
  • 80% say it will take a year of more for revenues to recover
  • Shareholders and investors are the CFO’s most challenging stakeholder
  • 74% of CFOs believe the Chair provides effective support, compared to just 60% of CEOs
  • CFOs are less confident than CEOs in the senior team’s ability to navigate strategic uncertainty
Click here for the Criticaleye podcast. In episode one of our Leadership with New Horizons series, Criticaleye CEO Matthew Blagg and Director of Content Marc Barber cover key themes for leaders and senior executives in 2021.

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 224




Drax Group plc GlaxoSmithKline plc E.ON UK NATS Aldermore Group Lightsource bp London Stock Exchange Group NatWest Group Worldpay Rolls-Royce British Land LACE Partners Hitachi Solutions Canaccord Genuity Group Inc Legal & General AlixPartners